(Total Views: 775)
Posted On: 04/03/2024 10:43:46 PM
Post# of 154863
Back when REGNUM caught up to its overdue 10k filing it said that via SevenScore (which is what it intended to rename itself, but actually never did so)
"it would focus on developing and commercializing therapeutics that would treat rare and infectious diseases, specifically in populations that are neglected or face adherence challenges. SevenScore's primary asset is cfommercial rights of Leronlimab (PRO140 in ALL HIV indications within the United States." Butt,... this Mantra has always belonged to Phoenixus AG...a Swiss company that Shkreli owned 37% of the available stock. Regnum the "public" shell apparently made a US $1.5million loan from Phoenixus for the express purpose of "Clinical Development".
It's late... I'm going home.
incidentally... REGNUM is now a music company
"it would focus on developing and commercializing therapeutics that would treat rare and infectious diseases, specifically in populations that are neglected or face adherence challenges. SevenScore's primary asset is cfommercial rights of Leronlimab (PRO140 in ALL HIV indications within the United States." Butt,... this Mantra has always belonged to Phoenixus AG...a Swiss company that Shkreli owned 37% of the available stock. Regnum the "public" shell apparently made a US $1.5million loan from Phoenixus for the express purpose of "Clinical Development".
It's late... I'm going home.
incidentally... REGNUM is now a music company
(7)
(0)
